Is history of squamous-cell skin cancer a marker of poor prognosis in patients with cancer?

Annals of Internal Medicine

Volumn 131, Issue 9, 1999, Pages 655-659

  Askling, Johan ^a   Sørensen, Per ^b   Ekbom, Anders ^a   Frisch, Morten ^c   Melbye, Mads ^b   Glimelius, Bengt ^d   Hjalgrim, Henrik ^b   Hudson, Barbara ^e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STATENS SERUM INSTITUT   (Denmark)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANAMNESIS; ARTICLE; BREAST CANCER; CANCER MORTALITY; CHRONIC LYMPHATIC LEUKEMIA; COLON CANCER; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RISK ASSESSMENT; SECOND CANCER; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA;

EID: 0032754721     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-131-9-199911020-00004     Document Type: Article

References (26)

1. Adami J, Frisch M, Yuen J, Glimelius B, Melbye M. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. BMJ. 1995; 310:1491-5.
2. Frisch M, Melbye M. New primary cancers after squamous cell skin cancer. Am J Epidemiol. 1995;141:916-22.
3. Levi F, Randimbison L, La Vecchia C Erler G, Te VC Incidence of invasive cancers following squamous cell skin cancer. Am J Epidemiol. 1997;146:734-9.
4. Levi F, Randimbison L, Te VC La Vecchia C Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers. Br J Cancer. 1996:74:1847-50.
5. Wassberg C, Thörn M, Yuen J, Ringborg U, Hakulinen T. Second primary cancers in patients with squamous cell carcinoma of the skin: a population-based study in Sweden. IntJ Cancer. 1999;80:511-5.
6. Teppo L, Pukkala E, Saxen E. Multiple cancer-an epidemiologic exercise in Finland. J Natl Cancer Inst. 1985;75:207-17.
7. Frisch M, Hjalgrim H, Olsen JH, Melbye M. Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study. Ann Intern Med. 1996;125:815-21.
8. Levi F, La Vecchia C, Te VC, Randimbison L, Erler G. Incidence of invasive cancers following basal cell skin cancer. Am J Epidemiol. 1998; 147:722-6.
9. Kahn HS. Tatham LM, Patel AV, Thun MJ, Heath CW Increased cancer mortality following a history of nonmelanoma skin cancer. JAMA. 1998;280:910-2.
10. Hjalgrim H, Frisch M, Storm H, Glimelius B, Pedersen JB, Melbye M. Non-melanoma skin cancer may be a marker of poor prognosis in patients with non-Hodgkin's lymphoma. Int J Cancer. [In press].
11. Harris ML. Jaffe ES, Stein H, Banks PM, Chan JK, deary ML. et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994:84:1361-92.
12. Lunde AS, Lundeborg S, Lettenstrom GS, Thygesen L, Huebner J. The person-number systems of Sweden, Norway, Denmark, and Israel. Vital Health Stat 2. 1980:2:1-59.
13. Clayton D, Hills M. Statistical Methods in Epidemiology. Oxford: Oxford Univ Pr; 1993.
14. Teppo L, Dickman PW, Hakulinen T, Luostarinen T, Pukkala E, Sankila R, et al. Cancer patient survival-patterns, comparisons, trends-a population-based Cancer Registry study in Finland. Acta Oncol. 1999:38:283-94.
15. Stenbeck M, Rosen M, Holm LE. Cancer survival in Sweden during three decades, 1961-1991. Acta Oncol. 1995:34:881-91.
16. A prospective survey of radiotherapy in Sweden. Acta Oncol. 1996;35(Suppl 6): 47-56.
17. Adami HO, Bergstrom R, Engholm G, Nyren O, Wölk A, Ekbom A, et al. A prospective study of smoking and risk of prostate cancer. Int J Cancer. 1996:67:764-8.
18. Dreyer L, Winther JF, Pukkala E, Andersen A. Avoidable cancers in the Nordic countries. Tobacco smoking. APMIS Suppl. 1997;76:9-47.
19. Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol. 1984;23:305-13.
20. Kinlen LJ. Immunosuppression and cancer. IARC Sei Publ. 1992; 116:237-53.
21. Birkeland SA, Storm HH, Lamm LU, Barlow L, Blohme I, Forsberg B, et al. Cancer risk after renal transplantation in the Nordic countries. 1964-1986. IntJ Cancer. 1995:60:183-9.
22. Clerici M, Shearer GM. Clerici E. Cytokine dysregulation in invasive cervical carcinoma and other human neoplasias: time to consider the TH1/TH2 paradigm (Editorial], J Natl Cancer Inst. 1998,90:261-3.
23. Lucey DR, Clerici M, Shearer GM. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev. 1996:9:532-62.
24. Au WW, Wilkinson GS, Tyring SK, Legator MS, el Zein R, Hallberg L, et al. Monitoring populations for DNA repair deficiency and for cancer susceptibility. Environ Health Perspect. 1996;104(Suppl 3):579-84.
25. Wei Q, Matanoski GM, Farmer ER, Hedayati MA, Grossman L. DNA repair related to multiple skin cancers and drug use. Cancer Res. 1994;54: 437-40.
26. Brash DE, Rudolph JA, Simon JA. Lin A, McKenna GJ, Baden HP, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sei USA. 1991;88:10124-8.